Concepedia

A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma

Richard M. Goldberg, Charles G. Moertel, H. Samuel Wieand, James E. Krook, Allan J. Schutt, Michael H. Veeder, James A. Mailliard, Robert J. Dalton

Cancer · 1995 · 45 citations · 8 references

DOIFull text

Open access

Abstract

Octreotide at a dose of 150 micrograms given three times daily is not effective therapy for patients with advanced asymptomatic colon carcinoma.

References

8

Oncological applications of somatostatin analogues.

Andrew V. Schally · PubMed · 1988 · 483 citations

, , +2

Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.

Louis Buscail, Nathalie Delesque, J.P. Estève et al. · Proceedings of the National Academy of Sciences · 1994 · 330 citations · Full text

, , +21

Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells.

Buddy Setyono-Han, M.S. Henkelman, John A. Foekens et al. · PubMed · 1987 · 191 citations

, , +14

SOMATOSTATIN INHIBITS RAPID CENTROSOMAL SEPARATION AND CELL PROLIFERATION INDUCED BY EPIDERMAL GROWTH FACTOR.

Renato N. Mascardo, P Sherline · Endocrinology · 1982 · 130 citations

In vitro and in vivo inhibition of human small cell lung carcinoma (NCl-H69) growth by a somatostatin analogue

John E. Taylor, Arthur E. Bogdén, Jacques-Pierre Moreau et al. · Biochemical and Biophysical Research Communications · 1988 · 128 citations

, , +10